Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.

The Journal of Experimental Medicine
Clémentine SchilteMatthew L Albert

Abstract

Chikungunya virus (CHIKV) is the causative agent of an outbreak that began in La Réunion in 2005 and remains a major public health concern in India, Southeast Asia, and southern Europe. CHIKV is transmitted to humans by mosquitoes and the associated disease is characterized by fever, myalgia, arthralgia, and rash. As viral load in infected patients declines before the appearance of neutralizing antibodies, we studied the role of type I interferon (IFN) in CHIKV pathogenesis. Based on human studies and mouse experimentation, we show that CHIKV does not directly stimulate type I IFN production in immune cells. Instead, infected nonhematopoietic cells sense viral RNA in a Cardif-dependent manner and participate in the control of infection through their production of type I IFNs. Although the Cardif signaling pathway contributes to the immune response, we also find evidence for a MyD88-dependent sensor that is critical for preventing viral dissemination. Moreover, we demonstrate that IFN-alpha/beta receptor (IFNAR) expression is required in the periphery but not on immune cells, as IFNAR(-/-)-->WT bone marrow chimeras are capable of clearing the infection, whereas WT-->IFNAR(-/-) chimeras succumb. This study defines an essential ro...Continue Reading

References

Mar 1, 1989·The Journal of General Virology·I Greiser-WilkeL T Figueiredo
Jan 1, 1969·Transactions of the Royal Society of Tropical Medicine and Hygiene·D E CareyR Reuben
Apr 1, 1996·Trends in Biotechnology·P BerglundP Liljeström
Jan 7, 2000·Journal of Virology·G H MacDonald, R E Johnston
Jul 11, 2000·Nature Medicine·S J WuS S Frankel
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·John C RassaSusan R Ross
Aug 7, 2002·Journal of Virology·Karen BiebackSibylle Schneider-Schaulies
Dec 7, 2002·Nature Immunology·Paul SheppardKevin M Klucher
Mar 29, 2003·Journal of Virology·Teresa ComptonRobert W Finberg
Feb 22, 1964·Nature·R M FRIEDMAN
Feb 21, 2004·Science·Sandra S DieboldCaetano Reis e Sousa
Jul 16, 2004·Journal of Virology·Vincent van PeschThomas Michiels
Feb 16, 2005·Nature·Oliver SchulzCaetano Reis e Sousa
Jan 21, 2006·Nature Immunology·Taro Kawai, Shizuo Akira
Mar 7, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Colin Havenar-DaughtonKaja Murali-Krishna
May 16, 2006·La Revue de médecine interne·F SimonP Jeandel
May 17, 2006·PLoS Medicine·Isabelle SchuffeneckerSylvain Brisse
Jul 18, 2006·Lancet·Patrick Bodenmann, Blaise Genton
Sep 19, 2006·Immunity·Daniel B Stetson, Ruslan Medzhitov
Jan 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Deborah J LenschowHerbert Whiting Virgin
Apr 24, 2007·The Lancet Infectious Diseases·Dileep MavalankarParvathy Raman
May 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gianandrea BorgheriniFabrice Paganin
May 16, 2007·The Journal of Experimental Medicine·Cecilia JohanssonBrian L Kelsall
Jul 3, 2007·PLoS Pathogens·Marion SourisseauOlivier Schwartz
Sep 15, 2007·BMJ : British Medical Journal·Rory Watson

❮ Previous
Next ❯

Citations

Jan 22, 2013·Archives of Virology·Jyoti RanaSanjay Gupta
Jul 3, 2013·Antiviral Research·Simon-Djamel ThibervilleXavier de Lamballerie
Oct 2, 2013·Journal of Medicinal Chemistry·Adel A RashadPaul A Keller
Jun 17, 2010·Nature Reviews. Microbiology·Olivier Schwartz, Matthew L Albert
Feb 9, 2012·Proceedings of the National Academy of Sciences of the United States of America·Giovanna ClavarinoPhilippe Pierre
Apr 18, 2012·The Journal of Experimental Medicine·Pierre-Emmanuel JoubertMatthew L Albert
Jan 14, 2011·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Shilpi Verma, Chris A Benedict
Jun 19, 2012·The Journal of Infectious Diseases·Thérèse CoudercMarc Grandadam
Mar 15, 2013·Journal of Virology·Kristin M LongMark T Heise
Nov 20, 2012·The Journal of Clinical Investigation·Terk-Shin TengLisa F P Ng
Apr 5, 2013·PLoS Neglected Tropical Diseases·Clémentine SchilteAlain Michault
Oct 3, 2013·PloS One·Rachy AbrahamEaswaran Sreekumar
Sep 27, 2013·BioMed Research International·Iranaia Assunção-MirandaAndrea T Da Poian
Mar 24, 2012·Current Opinion in Virology·Andreas WackAnne O'Garra
Jun 13, 2012·Cellular Microbiology·Bor Luen Tang
Mar 18, 2011·Reviews in Medical Virology·Sunit Kumar Singh, Salini Krishnan Unni
Jul 24, 2014·The Journal of General Virology·Wadie D Mahauad-FernandezChioma M Okeoma
Oct 30, 2014·The Journal of General Virology·Adam TaylorSuresh Mahalingam
Jun 2, 2012·Current Opinion in Immunology·Stephanie Boisson-DupuisJean-Laurent Casanova
Jul 15, 2015·Antiviral Research·Thérèse Couderc, Marc Lecuit
Jun 21, 2015·Antiviral Research·Fok-Moon Lum, Lisa F P Ng

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
FACS
SMA
flow cytometry
transfection

Software Mentioned

AxioVision
FlowJo
Cardif

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.